Abstract
Snake toxins consist of different pharmacologically lively peptides and proteins. These hemorrhagic proteins are metalloproteinases with molecular weights between 20 to 100 kDa. SVMPs are zinc-dependent types and with a multidomain association. SVMPs consist of only the proteinase type of domain, while some contain other types such as cysteine, lectin and disintegrins. They are analogous with both MMP and ADAMs group. SVMPs are 30% of the total protein of snake’s venoms. Hemorrhagic activity and the stimulation of local and systemic bleeding generally are due to SVMPs. Necrosis, skin damage, inflammatory reaction, arthritis and are responsible for causing paralysis. These proteinase types also hold diverse functions such as the disruption of hemostasis, platelet aggregation and pro-inflammatory activities. This short review focuses on the most prominent effects induced by SVMPs.
Keywords: ADAMs, hemorrhagic proteins, inflammation, MMP, SVMPs.
Graphical Abstract
Current Chemical Biology
Title:Snake Venom Metalloproteinases: Structure, Mechanism and Induced Diseases
Volume: 8 Issue: 2
Author(s): Atul Kaushik, Anghesom Ambesajir and Jeevan J. Kaushik
Affiliation:
Keywords: ADAMs, hemorrhagic proteins, inflammation, MMP, SVMPs.
Abstract: Snake toxins consist of different pharmacologically lively peptides and proteins. These hemorrhagic proteins are metalloproteinases with molecular weights between 20 to 100 kDa. SVMPs are zinc-dependent types and with a multidomain association. SVMPs consist of only the proteinase type of domain, while some contain other types such as cysteine, lectin and disintegrins. They are analogous with both MMP and ADAMs group. SVMPs are 30% of the total protein of snake’s venoms. Hemorrhagic activity and the stimulation of local and systemic bleeding generally are due to SVMPs. Necrosis, skin damage, inflammatory reaction, arthritis and are responsible for causing paralysis. These proteinase types also hold diverse functions such as the disruption of hemostasis, platelet aggregation and pro-inflammatory activities. This short review focuses on the most prominent effects induced by SVMPs.
Export Options
About this article
Cite this article as:
Kaushik Atul, Ambesajir Anghesom and Kaushik J. Jeevan, Snake Venom Metalloproteinases: Structure, Mechanism and Induced Diseases, Current Chemical Biology 2014; 8 (2) . https://dx.doi.org/10.2174/221279680802150406152316
DOI https://dx.doi.org/10.2174/221279680802150406152316 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Current Pharmaceutical Design Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
Current Pharmaceutical Design Integrated Therapeutic Approaches in Head and Neck Cancer: The Importance of Multidisciplinary Team Management
Anti-Cancer Agents in Medicinal Chemistry RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins
Current Molecular Medicine Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Neuromyelitis Optica (NMO IgG+) and Genetic Susceptibility, Potential Ethnic Influences
Central Nervous System Agents in Medicinal Chemistry Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
Current Medicinal Chemistry The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
Current Medicinal Chemistry B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Update on ICOS: A Possible Target for Turning-Off Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Cardiovascular & Hematological Disorders-Drug Targets Small Molecule Inhibitors of PKCθ as Potential Antiinflammatory Therapeutics
Current Topics in Medicinal Chemistry Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews Monoclonal Antibodies in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine
Current Pharmaceutical Design Multiple Sclerosis – Established and Novel Therapeutic Approaches
Central Nervous System Agents in Medicinal Chemistry Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Humanized Cobra Venom Factor: Experimental Therapeutics for Targeted Complement Activation and Complement Depletion
Current Pharmaceutical Design LFA-1 as a Key Regulator of Immune Function: Approaches toward the Development of LFA-1-Based Therapeutics
Current Pharmaceutical Design